Via the IPMenu site:
The January/February issue of the WIPO Magazine is now available on the WIPO website.
Includes articles on:
Intellectual Property as a Lever for Economic Growth – The Latin American and Caribbean Experience; Coffee Exports, Product Differentiation and Branding; Dealing with Violators of Intellectual Property Rights;
Learning the Lessons of Traditional Knowledge: Broadening the Base [...]
Monthly Archives: February 2004
WIPO – January / February Issue WIPO Magazine
Litigation of EP Patents
From the IPMenu site:
Litigation of EP Patents
The EPO have set up a page which provides details of documents relating to the framework of the Working Party on Litigation set up by the Contracting States of the European Patent Organisation. List of available documents:
- European Patent Litigation Agreement: Introductory remarks
- Declaration adopted by the Working [...]
USPTO-Revised Procedures for Papers Requiring Immediate Attention
Revised Procedures for Papers Requiring Immediate Attention
February 26, 2004
On October 28, 2003 the Office published new procedures for the centralized delivery of documents (see Centralized Delivery and Facsimile Transmission Requirements for Patent Application Related Correspondence, 1275 Off. Gaz. Pat. Office 200 (Oct. 28, 2003)). These procedures were revised on February 2, 2004. (cf. Papers Requiring [...]
USPTO-Waiver of 37 CFR1.312
Waiver of 37 CFR1.312 for Documents Required by the Office of Patent Publication
February 24, 2004
In preparation of a patent for issuance as a patent grant, if the Office of Patent Publication discovers an error in the text, or drawings of a patent application, including any missing text, or an inconsistency between the drawings and the [...]
Pfizer, Inc., v. Dr. Reddy’s Laboratories, Ltd., et al. (Federal Circuit)
Pfizer, Inc., v. Dr. Reddy’s Laboratories, Ltd., et al.
Federal Circuit
February 27, 2004
Before MAYER, Chief Judge, NEWMAN and LOURIE, Circuit Judges. Opinion by NEWMAN, dissenting opinion by MAYER.
Pfizer’s patent (USPN 4,572,909) covers Norvasc®, an anti-hypertensive, anti-ischemic drug product whose active ingredient is amlodipine. The specification describes clinical data of amlodipine besylate and amlodipine maleate. Pfizer selected [...]
Patent Business Methods Partnership Meeting @ USPTO
Patent Business Methods Partnership Meeting
As part of the March 2000 business method action plan, the United States Patent and Trademark Office (USPTO) announces the Spring 2004 business methods customer partnership meeting to be hosted by the director and managers of the Business Methods workgroup. Members of the public are invited to attend the partnership meeting [...]
February JPTOS
The February JPTOS is out.
Articles: “Celebrating the Life of Isaac Fleischmann”; “Festo is Back! On Remand the Federal Circuit Answers Four More Questions?”; “The Community Design: A New Right of Design Protection for the European Community”; “Enforcement of CTMS in the EU: The Real Test of Their Commercial Value”; and “An [...]
Third Annual Hot Topics in IP Symposium
Via Carey’s Blog
Who: Duke Law Intellectual Property & Cyberlaw Society
What: Third Annual Hot Topics in IP Symposium
When: March 26, 2004
Where: Durham, NC
Details at http://intprop.law.duke.edu
TechnoLawyer
One thing you should consider is joining the “TechnoLawyer Community.” I have received a lot of benefit over the past few years from this FREE service.
What Is TechnoLawyer?
TechnoLawyer consists of: (1) TechnoLawyer Newsletters, a network of FREE, critically-acclaimed e-mail newsletters for legal professionals; and (2) TechnoLawyer Archive, a searchable Web-based repository of [...]
USPTO – Nanotechnology Customer Partnership Meeting
“This Nanotechnology Customer Partnership initiative is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at a group consensus. Individual opinions are sought from varying participants, and the meetings are intended to [...]
